The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreNov 2020
US$2,650Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Consumer health in the United Arab Emirates is set to record a positive performance in 2020, with the outbreak of the COVID-19 pandemic contributing as one of the major reasons for the growth. However, overall demand for many categories is set to be more subdued after initial stockpiling during lockdown in Q1 considering the recessionary macroeconomic pressures on the industry.
From 23 March, the government urged people to only leave their homes to go to work or in an emergency. On 31 March, Al Ras, one of Dubai's most densely populated areas, was placed under lockdown for two weeks, preventing all residents from leaving or entering the area.
GSK Consumer Healthcare continues to lead consumer health in the United Arab Emirates, following the 2019 merger of GlaxoSmithKline and Pfizer with their strong combined portfolio which includes Panadol, Voltaren, Otrivin and Zyrtec, leaving GSK Consumer Healthcare as the only player to hold double-digit value share in 2020. However, like all major players in the market, growing price sensitivity amongst the population is set to lead to greater share gain for smaller players under “others” in an increasingly fragmented competitive landscape.
The United Arab Emirates had one of the strictest lockdowns in the world, with weeks of 24-hour curfew while consumers needed a permit from the police even to enter grocery retailers and chemists/pharmacies. However, both of these distribution channels were open for extended periods during these weeks of lockdown.
Recovery for consumer health in the United Arab Emirates is likely to return from 2021-2022 onwards although there continues to be a high level of uncertainty over its growth trajectory as this will depend on whether a vaccine emerges over the early part of the forecast period. As of September 2020, the country had invested in conducting its own vaccine trials, resulting in a greater sense of optimism in the country.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in United Arab Emirates with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Consumer Health industry in United Arab Emirates, our research will save you time and money while empowering you to make informed, profitable decisions.
When you purchase this report, you also get the data and the content from these category reports in United Arab Emirates for free:
The Consumer Health in United Arab Emirates market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.